The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review
- PMID: 32012861
- PMCID: PMC7037192
- DOI: 10.3390/ijms21030826
The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review
Abstract
Major depressive disorder (MDD) is the leading cause of disability worldwide and is associated with high rates of suicide and medical comorbidities. Current antidepressant medications are suboptimal, as most MDD patients fail to achieve complete remission from symptoms. At present, clinicians are unable to predict which antidepressant is most effective for a particular patient, exposing patients to multiple medication trials and side effects. Since MDD's etiology includes interactions between genes and environment, the epigenome is of interest for predictive utility and treatment monitoring. Epigenetic mechanisms of antidepressant medications are incompletely understood. Differences in epigenetic profiles may impact treatment response. A systematic literature search yielded 24 studies reporting the interaction between antidepressants and eight genes (BDNF, MAOA, SLC6A2, SLC6A4, HTR1A, HTR1B, IL6, IL11) and whole genome methylation. Methylation of certain sites within BDNF, SLC6A4, HTR1A, HTR1B, IL11, and the whole genome was predictive of antidepressant response. Comparing DNA methylation in patients during depressive episodes, during treatment, in remission, and after antidepressant cessation would help clarify the influence of antidepressant medications on DNA methylation. Individuals' unique methylation profiles may be used clinically for personalization of antidepressant choice in the future.
Keywords: DNA; antidepressants; epigenetics; methylation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
The impact of HTR1A and HTR1B methylation combined with stress/genotype on early antidepressant efficacy.Psychiatry Clin Neurosci. 2022 Feb;76(2):51-57. doi: 10.1111/pcn.13314. Epub 2021 Dec 7. Psychiatry Clin Neurosci. 2022. PMID: 34773671
-
DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations.Neurosci Lett. 2018 Mar 16;669:14-23. doi: 10.1016/j.neulet.2016.12.071. Epub 2017 Jan 4. Neurosci Lett. 2018. PMID: 28063933 Review.
-
HTR1A/1B DNA methylation may predict escitalopram treatment response in depressed Chinese Han patients.J Affect Disord. 2018 Mar 1;228:222-228. doi: 10.1016/j.jad.2017.12.010. Epub 2017 Dec 7. J Affect Disord. 2018. PMID: 29275155
-
Epigenome-Wide DNA Methylation in Unipolar Depression: Predictive Biomarker of Antidepressant Treatment Response?Int J Neuropsychopharmacol. 2024 Nov 1;27(11):pyae045. doi: 10.1093/ijnp/pyae045. Int J Neuropsychopharmacol. 2024. PMID: 39367879 Free PMC article.
-
DNA Methylation in Depression and Depressive-Like Phenotype: Biomarker or Target of Pharmacological Intervention?Curr Neuropharmacol. 2022 Nov 15;20(12):2267-2291. doi: 10.2174/1570159X20666220201084536. Curr Neuropharmacol. 2022. PMID: 35105292 Free PMC article. Review.
Cited by
-
Early Life Stress Induced DNA Methylation of Monoamine Oxidases Leads to Depressive-Like Behavior.Front Cell Dev Biol. 2020 Sep 8;8:582247. doi: 10.3389/fcell.2020.582247. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33015076 Free PMC article. Review.
-
A systematic mini-review of epigenetic mechanisms associated with electroconvulsive therapy in humans.Front Hum Neurosci. 2023 Mar 9;17:1143332. doi: 10.3389/fnhum.2023.1143332. eCollection 2023. Front Hum Neurosci. 2023. PMID: 36968786 Free PMC article. Review.
-
Brain region-specific roles of brain-derived neurotrophic factor in social stress-induced depressive-like behavior.Neural Regen Res. 2025 Jan 1;20(1):159-173. doi: 10.4103/NRR.NRR-D-23-01419. Epub 2024 Apr 3. Neural Regen Res. 2025. PMID: 38767484 Free PMC article.
-
Models for depression recognition and efficacy assessment based on clinical and sequencing data.Heliyon. 2024 Jul 4;10(14):e33973. doi: 10.1016/j.heliyon.2024.e33973. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39130405 Free PMC article.
-
BDNF exon IV promoter methylation and antidepressant action: a complex interplay.Clin Epigenetics. 2022 Dec 26;14(1):187. doi: 10.1186/s13148-022-01415-3. Clin Epigenetics. 2022. PMID: 36572893 Free PMC article.
References
-
- World Health Organization . Depression and Other Common Mental Disorders Global Health Estimates. World Health Organization; Geneva, Switzerland: 2017. pp. 1–24.
-
- Marcus M., Yasamy M.T., van Ommeren M., Chisholm D., Saxena S. Depression A Global Public Health Concern. WHO Department of Mental Health and Substance Abuse; [(accessed on 27 January 2020)]. Available online: https://www.who.int/mental_health/management/depression/who_paper_depres....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical